JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 5 840-845
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Özker, K.
Right arrow Articles by Urgancioglu, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Özker, K.
Right arrow Articles by Urgancioglu, I.

Technetium-99m-N,N-Ethylenedicysteine—A Comparative Study of Renal Scintigraphy with Technetium-99m-MAG3 and Iodine-131-OIH in Patients with Obstructive Renal Disease

Kutlan Özker, çetin Önsel, Levent Kabasakal, Haluk Burçak Sayman, Ilhami Uslu, Sükrü Bozluolçay, Tülay Cansiz, Tarik Kapicioglu and Irfan Urgancioglu

Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul, Turkey

Correspondence: For correspondence or reprints contact: Levent Kabasakal, MD, Nükleer Tip Anabilim Dali Cerrahpasa Tip Fakültesi, Aksaray, Istanbul, Turkey.

ABSTRACT

Technetium-99m-labeled N,N-ethylenedicysteine (99mTc-EC) is a new renal imaging agent introduced as an alternative for 99mTc-labeled mercaptoacetyltriglycine (99mTc-MAG3), with similar renal excretion characteristics. To evaluate the diagnostic characteristics of this agent, a gamma camera study was performed. Methods: Sixteen patients with obstructive renal disease and six normal controls were injected with 90 to 110 MBq of 99mTc-EC and 7.4 MBq 131I-labeled orthoiodohippurate (OIH). Serial images were obtained during 20 min for 99mTc-EC and 30 min for OIH. The study was repeated using 90 to 110 MBq 99mTc-MAG3 during the same week. Results: Renograms, functional ratios and urinary excretion patterns of all three agents were similar. The mean time to peak activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 4.25 ± 0.37 min, 4.39 ± 0.32 min and 4.00 ± 0.24 min, respectively. The time from peak to 50% activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 5.48 ± 0.80 min, 6.93 ± 0.69 min and 7.33 ± 0.85 min, respectively. Conclusion: It is concluded that 99mTc-EC has excellent imaging characteristics and similar excretion properties to OIH. The advantages of 99mTc-EC over 99mTc-MAG3 are lower hepatobiliary uptake and simplicity of preparation.

Key Words: ethylenedicysteine • MAG3 • OIH • renogram




This article has been cited by other articles:


Home page
JNMHome page
D. Eshima, L. Eshima, L. Hansen, M. Lipowska, L. G. Marzilli, and A. Taylor Jr
Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents
J. Nucl. Med., December 1, 2000; 41(12): 2077 - 2082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.